| Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Beta Agonists   
| Nonselective α, β1, and β2 agonist; bronchodilation plus all other sympathomimetic effects on cardiovascular and other systems | Tachycardia, arrhythmias, worsening angina pectoris | Acute vasodilation, shock, and bronchospasm of anaphylaxis
 
 |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Beta Agonists   
| β1 and β2 agonist; bronchodilation & powerful cardiovascular effects | Cardiac arrhythmias from high doses ↑ mortality | Asthma, but β2 selective preferred |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Beta Agonists   
| Selective β2 agonist; prompt bronchodilation | Tremor, tachycardia, overdose arrhythmias | Asthma, COPD, drug of choice in acute asthmatic bronchospasm |    |  | 
        |  | 
        
        | Term 
 
        | Metaproterenol and other "nol and rol"s |  | Definition 
 
        | CH 20 Drugs Used in Asthma Beta Agonists   
| Selective β2 agonist; prompt bronchodilation | Tremor, tachycardia, overdose arrhythmias | Asthma, COPD, drug of choice in acute asthmatic bronchospasm |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Beta Agonists   
| Only β2 agonist available for subcutaneous injection | “ | “ |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Corticosteroids (inhaled) 
| Broad anti-inflammatory efficacy, inhibit production of cytokines; inhibit infiltration of asthmatic airways by lymphocytes, eosinophils, and mast cells | Dysphonia   Oropharyngeal candidiasis (opportunistic mucosal fungal infection) – patients must gargle and spit after each use;hoarseness
 | Do not relax smooth muscle directly but reduce bronchial reactivity and frequency of asthmatic exacerbations if taken regularly |  |  
|  |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Corticosteroids (inhaled)   
| Broad anti-inflammatory efficacy, inhibit production of cytokines; inhibit infiltration of asthmatic airways by lymphocytes, eosinophils, and mast cells | Dysphonia 
 Oropharyngeal candidiasis (opportunistic mucosal fungal infection) – patients must gargle and spit after each use;hoarseness
 | Do not relax smooth muscle directly but reduce bronchial reactivity and frequency of asthmatic exacerbations if taken regularly |  |  
|  |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Corticosteroids (oral)   
| Systemic, anti-inflammatory | *Adrenal suppressionSignificant adverse side effects – psychiatric and GI symptoms, etc.
 | Many inflammatory diseases including asthma and COPD |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Mast Cell Degranulation Inhibitor   
| Must be taken prophylactically; alters function of delayed Cl- channels, thus inhibiting inflammatory cell activation | Minor and localized – throat irritation, cough, mouth dryness | Allergic rhinoconjunctivitis
 not as potent as corticosteroids
 |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Methylxanthines   
| Uncertain - phosphodiesterase inhibition, adenosine receptor antagonist;  bronchodilation, cardiac stimulation, ↑ skeletal muscle strength (diaphragm) | Anorexia, nausea, vomiting, abdominal discomfort, headache, anxiety (15-20mg/L plasma);Seizures or arrhythmias (40mg/L)
 | Asthma, COPD
 narrow therapeutic window
 |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Leukotriene Antagonists   
| Block leukotriene D4 receptors; block airway response to exercise and antigen challenge | minimal | Prophylaxis of asthma, especially in children and in aspirin-induced asthma |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Leukotriene Antagonists   
| Inhibits lipoxygenase, reduces synthesis of leukotrienes | Occasional liver toxicity | “ |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma IgE Antibody   
| Inhibits binding of IgE to mast cells but does not activate IgE already bound to these cells; reduce frequency and severity of asthmatic exacerbations  |   | Severe asthma inadequately controlled by other agents |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Antimuscarinic Drugs   
| Competitively inhibit the effect of acetylcholine at muscarinic receptors; block contraction of airway smooth muscle and the ↑ in secretion of mucus that occurs in response to ACh release from vagal nerves; does not enter CNS | Dry mouth, sedation | Less effective than β-agonist in reversing asthmatic bronchospasm, but enhances bronchodilation;  COPD |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 20 Drugs Used in Asthma Antimuscarinic Drugs   
| Longer-acting, selective antimuscarinic agent | Dry mouth, throat irritation | COPD |    |  | 
        |  |